Top Markets
Coin of the day
Amniotics AB (publ) Amniotics AB (publ)

Amniotics AB (publ)

AMNI
Kedudukan dalam Saham #37511
Amniotics AB (publ) specializes in the creation, manufacturing, and... Amniotics AB (publ) specializes in the creation, manufacturing, and commercialization of stem cell-based therapies, utilizing mesenchymal stem cells to address critical, life-threatening illnesses. The company's primary therapeutic candidate, PulmoStem, is designed for the treatment of inflammatory and fibrotic conditions affecting the lungs. Furthermore, Amniotics is advancing other promising treatments such as CogniStem for neurological disorders, NephroStem for kidney-specific ailments, and CutiStem for various dermatological issues. Beyond its own pipeline, the firm provides contract development and manufacturing services for advanced therapy medicinal products to pharmaceutical companies, universities, and hospitals. Established in 2015, Amniotics AB is headquartered in Lund, Sweden.
Harga Saham
$0.00060315
Disegerakkan terakhir: 2024-09-27
Modal Pasaran
$1.65M
Perubahan (1 hari)
19.64%
Perubahan (1 tahun)
0.00%
Negara
SE
Perdagangan Amniotics AB (publ) (AMNI)

Kategori

Bilangan saham terbitan bagi Amniotics AB (publ) (AMNI)
Bilangan saham terbitan setakat December 2023: 1.46B
Menurut laporan kewangan terkini dan harga saham Amniotics AB (publ), bilangan saham terbitan semasa ialah 1.46B. Pada akhir December 2022, syarikat mempunyai 164.84M saham terbitan. Bilangan saham terbitan biasanya dipengaruhi oleh pecahan saham dan pembelian balik saham.
Sejarah saham terbitan untuk Amniotics AB (publ) (AMNI) dari 2018 hingga 2026
Saham terbitan pada akhir setiap tahun
Tahun Saham Terbitan Ubah
2026 (TTM) 1.46B -47.99%
2023 2.81B 1,602.50%
2022 164.84M 0.00%
2021 164.84M -10.30%
2020 183.76M 0.00%
2019 183.76M 0.00%
2018 183.76M 0.00%
Saham terbitan bagi syarikat atau pesaing yang serupa
Syarikat Saham Terbitan Perbezaan Negara
253.90M -82.60%
US
62.19M -95.74%
NL
- -
CH
- -
KR
0.00 -100.00%
BE